Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
117171752	11717175	2	F	20001024	20160826	20151109	20160826	EXP		BE-BRISTOL-MYERS SQUIBB COMPANY-2001SUS0512	BRISTOL MYERS SQUIBB		0.00				Y	0.19000	KG	20160826		MD	BE	BE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	NDA NUM	DOSE FORM
117171752	11717175	1	PS	SUSTIVA	EFAVIRENZ	1	Transplacental	UNK	U	20972	CAPSULE
117171752	11717175	2	C	INDINAVIR	INDINAVIR	1	Transplacental	UNK	U	0
117171752	11717175	3	C	ABACAVIR.	ABACAVIR	1	Transplacental	UNK	U	0

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
117171752	11717175	1	Product used for unknown indication
117171752	11717175	2	Product used for unknown indication
117171752	11717175	3	Product used for unknown indication

Outcome of event

Reactions reported

Event ID	CASEID	PT
117171752	11717175	Foetal exposure during pregnancy
117171752	11717175	Foetal growth restriction
117171752	11717175	Placental disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

no results found

no results found